14 January 2026
Working with expert groups and clinical governance committees
In areas of clinical practice where high-quality information is unavailable or limited, BNF and BNFC editorial team members work with expert advisory groups and BNF and BNFC clinical governance committees to create clinical recommendations based on the best available evidence, i.e. ‘BNF-authored’ recommendations. The rigorous content creation process followed by the editorial team is described here.
In 2025, we worked with many expert groups and the BNF and BNFC governance committees to create clinical recommendations to support health professionals working in various areas of clinical practice. This has resulted in updates to both drug monograph and treatment summary content; examples include:
- Oral iron for iron-deficiency anaemia in children: new regimen with reduced frequency of dosing (BNFC)
- Malaria: dosing for piperaquine phosphate with artenimol for management of treatment failure, and new UK licensed preparation of intravenous artesunate (BNF and BNFC)
- New dosing regimen for continuous intravenous infusion of vancomycin in neonates (BNFC)
- Updates to pregnancy and breast-feeding information:
- Chloroquine: updated pregnancy and breast-feeding advice when used for rheumatic disease (BNF)
- Hydroxychloroquine sulfate: updated pregnancy and breast-feeding advice (BNF and BNFC)
- Ulipristal acetate: updated breast-feeding advice (BNF and BNFC)
